Basic Information
| LncRNA/CircRNA Name | lncRNA-HEIH |
| Synonyms | HEIH, HCCAT2, LINC-HEIH, LINC00848, lncRNA-HEIH |
| Region | GRCh38_5:180829954-180831605 |
| Ensemble | ENSG00000278970 |
| Refseq | NR_045680 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cholangiocarcinoma |
| ICD-0-3 | NA |
| Methods | qRT-PCR |
| Sample | CHOL tissues , cell lines(QBC939, RBE, HuCCT1, TFK-1, CCLP1) |
| Expression Pattern | up-regulated |
| Function Description | HEIH promoted CHOL tumorigenesis and progression by miR-98-5p/HECTD4 axis |
| Pubmed ID | 32062383 |
| Year | 2020 |
| Title | LncRNA HEIH promotes cell proliferation, migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4 |
External Links
| Links for lncRNA-HEIH | GenBank HGNC NONCODE |
| Links for cholangiocarcinoma | OMIM COSMIC |